Treatment for Gastroesophageal Reflux Disease (GERD) in Children

Introduction to GERD Management

• The American Academy of Pediatrics recommends lifestyle modifications as the initial management strategy for GERD in children, followed by acid suppressants such as proton pump inhibitors (PPIs) or H2 receptor antagonists (H2RAs) if symptoms persist 1, 2

Lifestyle Modifications

• Weight loss is recommended if the child is overweight or obese, as part of the initial lifestyle modifications for GERD management 3, 4
• Avoiding foods that may trigger symptoms, such as spicy foods, chocolate, and caffeine, is advised for children with GERD 4
• Not smoking or using alcohol is recommended for adolescents with GERD, as part of the lifestyle modifications 4
• Chewing sugarless gum after meals can help increase saliva production and neutralize acid in children with GERD 4
• Elevating the head of the bed or maintaining an upright position after meals is recommended to reduce symptoms of GERD in children 1, 5

Pharmacological Treatment

• The American Academy of Pediatrics recommends H2 receptor antagonists (H2RAs) such as ranitidine (5-10 mg/kg/day divided in 2-3 doses) and famotidine (1 mg/kg/day divided in 2 doses) as first-line medications for GERD in children 2, 6
• Proton pump inhibitors (PPIs) such as omeprazole (0.7-3.3 mg/kg/day), lansoprazole (0.7-3 mg/kg/day), and esomeprazole (0.7-3.3 mg/kg/day) are recommended for children with GERD, with a treatment duration of typically 4-8 weeks 6, 1, 7
• PPIs are more effective than H2RAs for symptom relief and healing of erosive esophagitis in children with GERD 8

Potential Side Effects and Risks

• PPIs may increase the risk of community-acquired pneumonia and gastroenteritis in children with GERD 3, 8
• H2RAs may cause liver disease and gynecomastia (particularly with cimetidine) in children with GERD 3, 8
• Tachyphylaxis can occur within 6 weeks of initiation of H2RAs in children with GERD 8

Treatment Algorithm

• The initial approach to treating GERD in children involves lifestyle modifications for 2-4 weeks, followed by medication if symptoms persist 1, 4
• If symptoms persist, a trial of H2RA (e.g., famotidine) for 4 weeks is recommended for mild symptoms, while PPI (e.g., omeprazole) is recommended for moderate to severe symptoms or erosive esophagitis 6, 2

Monitoring and Referral

• Regular follow-up is necessary to assess symptom improvement and medication side effects in children with GERD 1
• Consideration of referral to a pediatric gastroenterologist is recommended if symptoms fail to respond to optimal medical therapy after 4-8 weeks, or if warning signs are present (poor weight gain, recurrent pneumonia, hematemesis) 1, 5

Pediatric GERD Treatment Guidelines

Lifestyle and Pharmacologic Interventions

• For breastfed infants with suspected GERD, a 2-4 week trial of maternal dietary elimination of milk and egg proteins is recommended, as cow's milk protein allergy can mimic GERD in up to 42-58% of cases, according to the American Academy of Pediatrics 9
• For formula-fed infants with suspected GERD, a trial of extensively hydrolyzed protein or amino acid-based formula for 2-4 weeks is suggested, as supported by the American Academy of Pediatrics 9
• Thickened feedings with up to 1 tablespoon of dry rice cereal per ounce of formula can reduce reflux symptoms in infants, as recommended by the American College of Chest Physicians 10
• Feeding adjustments, such as reducing feeding volume and increasing frequency, can minimize gastric distension in infants with GERD, according to the American Academy of Pediatrics 9
• The American College of Chest Physicians recommends limiting acid suppression therapy to 4-8 weeks when evaluating treatment efficacy in pediatric GERD patients 10, 11
• The American College of Chest Physicians advises against using acid suppressive therapy solely for chronic cough without other GERD symptoms, as evidence does not support this practice 10, 11
• Prolonged use of proton pump inhibitors (PPIs) can increase the risk of serious adverse events, including community-acquired pneumonia, gastroenteritis, and bone fractures, according to the American College of Chest Physicians 10, 11
• Referral to pediatric gastroenterology is recommended if symptoms fail to respond to optimal medical therapy after 4-8 weeks, as suggested by the American Academy of Pediatrics and the American College of Chest Physicians 9, 11
• The American Academy of Pediatrics recommends considering upper endoscopy with esophageal biopsy for patients with warning signs, including poor weight gain, unexplained anemia, or recurrent pneumonia 9
• Reassessment of treatment response after 4-8 weeks of therapy is recommended, and consideration of alternative diagnoses if symptoms persist, according to the American College of Chest Physicians and the American Academy of Pediatrics 9, 11